Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Change in Receivables (2016 - 2025)

GeoVax Labs' Change in Receivables history spans 15 years, with the latest figure at -$532771.0 for Q3 2025.

  • Quarterly results put Change in Receivables at -$532771.0 for Q3 2025, down 315.79% from a year ago — trailing twelve months through Dec 2025 was -$659409.0 (down 200.0% YoY), and the annual figure for FY2025 was -$659409.0, down 200.0%.
  • Change in Receivables for Q3 2025 was -$532771.0 at GeoVax Labs, up from -$964774.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $838136.0 in Q1 2025 to a low of -$964774.0 in Q2 2025.
  • The 4-year median for Change in Receivables is $49763.0 (2021), against an average of -$18266.3.
  • The sharpest move saw Change in Receivables surged 127.66% in 2022, then tumbled 420.87% in 2025.
  • Year by year, Change in Receivables stood at $49006.0 in 2021, then plummeted by 303.09% to -$99526.0 in 2022, then surged by 212.37% to $111835.0 in 2024, then crashed by 576.39% to -$532771.0 in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$532771.0, -$964774.0, and $838136.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.